We combine disciplined deal selection, financial structuring, and operational value creation with the lever most PE firms leave to chance: a systematic methodology for building leaders, teams, and cultures that perform.
Explore the ThesisFinancial engineering, operational playbooks, and disciplined execution are table stakes. We bring all of that — plus a systematic methodology for the variable that determines whether value creation plans actually work: the people inside the business.
Most PE firms evaluate people qualitatively — interview a bunch of candidates, do references, and hope for the best. When it works, it looks like genius. When it doesn't, it's the most expensive failure mode in private equity: the wrong leader in the wrong context, destroying value that took years to build.
Prosocial Holdings integrates human capital strategy into every phase of the investment lifecycle. We evaluate leadership capability, cultural health, organizational alignment, and frontline engagement with the same rigor the industry applies to financial diligence. Then we build it into the value creation plan from day one — not as a soft add-on, but as the primary multiplier of every other lever in the PE toolkit.
Your best-performing portfolio companies had the right market and the right team. Right now, team is mostly luck. What if it wasn't?
We target attractive, fragmented markets with structural tailwinds — people-intensive industries where the human capital methodology creates disproportionate advantage. Industry selection and operational fundamentals come first. The human system amplifies them.
Financial, operational, and human capital diligence run in parallel. We underwrite the people risk alongside every other variable — leadership capability, cultural health, organizational alignment — diagnosed, scored, and factored into the investment case before the deal closes.
This is our edge. We build structured systems for selecting leaders based on contextual fit, developing people through coaching and culture, and retaining through purpose and autonomy. Not HR. Engineered capability at the core of the business model.
We track cultural health, leadership development, frontline engagement, and talent retention alongside EBITDA growth, margin expansion, MOIC, and IRR. We measure both because they are inseparable: improvements in the human system show up in the financial results.
Every thesis needs a proving ground. Our first deployment targets direct primary care practices focused on menopause and perimenopause — a market experiencing explosive demand, clinical fragmentation, and a care model where the human system and the financial system are the same system.
More than 47 million women in the US are currently navigating perimenopause or menopause. The insurance-based system is failing them — visits are too short, providers are under-trained in hormonal health, and care is episodic rather than integrated. Direct primary care practices serving this population offer a fundamentally better model: longer visits, continuity of care, and a membership structure that aligns provider incentives with patient outcomes.
In this model, provider satisfaction drives patient retention, which drives revenue predictability, which drives valuation. Get the people right and the returns follow directly. This makes women's midlife health the ideal sector to demonstrate — with measurable returns — that systematic investment in people produces outsized financial outcomes.
Growing consumer demand for relationship-based, menopause-informed primary care. Burnout-driven provider migration from insurance-based to direct-pay models. Favorable unit economics with recurring membership revenue and strong margins.
Thousands of independent and small-group DPC practices with few institutional buyers. Clinician-founders are seeking operational partnership — not financial extraction. A highly fragmented market ready for thoughtful consolidation by a partner who shares their values.
Our values-driven approach gives us access to sellers who would never engage traditional PE. Clinician-founders who care about their teams and patients choose partners who share those values. This isn't just differentiation — it's a sourcing advantage that compounds with every relationship we build.
If you're a clinician-founder serving women in midlife — or considering launching a practice focused on menopause and perimenopause care — we'd like to explore what partnership could look like.
We provide the systems you need to grow without burning out — finance, marketing, HR, technology, and growth strategy — so you can focus on what you do best: caring for patients.
You retain clinical autonomy and meaningful ownership economics. We bring capital, operational support, and a systematic approach to building teams and culture — designed to protect and enhance what you've already created.
Whether you're looking to expand an existing practice, launch something new, or join a community of like-minded clinicians building the future of women's midlife care — we're building the infrastructure to make it possible.
Every investment starts with two questions: where is the financial opportunity, and where is the human system underperforming? Our four-phase process integrates traditional PE rigor with systematic human capital development — because the value creation plan only works if the people do.
Financial and operational diligence — market sizing, revenue quality, unit economics, regulatory landscape — run in parallel with human capital diligence: leadership capability, cultural health, organizational alignment, frontline engagement. Both are diagnosed, scored, and factored into the investment case. We underwrite the people risk alongside every other variable.
We build a dual-track value creation plan: operational improvement — revenue growth, margin expansion, infrastructure buildout — paired with cultural architecture. Deliberate culture design, behavioral systems, incentive alignment, and transparency. The operational plan and the people plan are one plan.
We evaluate, develop, and support leaders through behavioral science — not pedigree, not pattern matching. Structured coaching and growth plans replace the annual review. When the right person has a real gap, we close it before it becomes a performance crisis.
We track cultural health, leadership development, frontline engagement, and talent retention alongside financial performance — EBITDA growth, margin expansion, MOIC, and IRR. Exit planning connects people metrics to enterprise value. We measure both because they are inseparable.
Through Brones & Company, I've built a rigorous methodology for connecting leadership strategy to execution capability — grounded in behavioral science, operator experience, and deep work inside PE-backed portfolio companies. That methodology has been applied across leadership transitions, cultural transformations, and talent strategy engagements at the board and C-suite level, including active board service with MARS Energy.
The methodology didn't come from a textbook. It came from learning the hard way. Earlier in my career as a private equity investor, I saw firsthand what happens when you get leadership selection wrong — not once, but repeatedly across the industry. Impressive résumés that were wrong for the specific context. Leaders who looked right on paper but couldn't build trust with a team, adapt to a culture, or navigate the particular demands of a portfolio company in transition. Those decisions didn't just underperform financially — they caused real disruption for employees, customers, and the businesses we were trying to grow.
That experience set me on a years-long path to understand what actually predicts leadership success — not in the abstract, but in the specific context of a deal, a team, a culture, a moment. It led me into academia: founding the Entrepreneurship through Acquisition program at the University of Colorado Leeds School of Business, and guest lecturing at Northwestern's Kellogg School of Management and the University of Chicago Booth Graduate School of Business. Teaching forced me to systematize what I'd learned — to turn pattern recognition into frameworks, intuition into methodology.
Prosocial Holdings is where all of this converges. The investment experience. The talent methodology. The academic rigor. The fundamental conviction that the human system inside a business is the primary value creation lever that most of our industry has chosen to ignore. I'm not building this to advise from the sidelines. I'm building it to acquire and operate businesses where the thesis can be fully realized — starting with women's midlife health, where the connection between people and value is most direct.
Original essays on leadership, private equity talent strategy, CEO performance, and the intersection of human psychology with value creation. Written for investors, operators, and anyone building something serious — a space for the ideas that underpin the Prosocial thesis.
Read the PublicationWhether you're a capital partner who sees the human capital edge as a source of differentiated returns, a clinician-founder exploring what operational partnership could look like for your practice, or a deal sponsor looking for an operating partner with a systematic approach to value creation — this starts with a conversation.
shannon@prosocialholdings.com